Document is current
Any future updates will be listed below
-
Authors
Delenko, Julia https://orcid.org/0009-0004-1494-6259
Xue, Xiangying
Chatterjee, Prodyot K
Hyman, Nathaniel https://orcid.org/0009-0000-2951-5436
Shih, Andrew J https://orcid.org/0000-0001-8375-7313
Adelson, Robert P https://orcid.org/0000-0002-0888-5638
Safaric Tepes, Polona https://orcid.org/0000-0002-5833-739X
Gregersen, Peter K https://orcid.org/0000-0003-1613-1518
Metz, Christine N https://orcid.org/0000-0002-1013-1691
-
Funding
Funding for this research was provided by:
Northwell Health Innovations (TNCOR1, TNCOR1)
- License Information
-
More Information
Article History
Received: 17 March 2024
Accepted: 23 July 2024
First Online: 8 August 2024
Declarations
:
: This study was conducted with approval from the Institutional Review Board (IRB) of Northwell Health (IRB #13–376A). Written informed consent was obtained from all human subjects prior to their participation in this research.
: Only de-identified data is presented. Not applicable.
: The authors declare no competing interests.
: Dr. Peter K Gregersen and Dr. Christine N Metz launched the ROSE (Research OutSmarts Endometriosis) study over a decade ago to collect biological specimens (including menstrual effluent) and associated data from pat. The goals of the ROSE study are to improve our understanding of the pathogenesis of endometriosis to inform the development of non-invasive methods for detecting endometriosis and better treatments. The ROSE study team won the 2018 Northwell Health Innovation Challenge award.
